Completed Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) NCT05461430 Conditions Adenocarcinoma, Adenoma, Adnexal Diseases, +139 more Locations xCures — Oakland, California, United States View Trial Details